Vascular Solutions (VASC) Income Statement

Click line-items for a historical chart and %

Product revenue	41.66M
License and collaboration revenue
Total revenue	41.77M
Cost of goods sold	14.86M
Collaboration expenses	0
Research and development	5.59M
Clinical and regulatory
Sales and marketing	9.22M
General and administrative	2.39M
Litigation
Amortization of purchased technology and intangibles	404K
Total product costs and operating expenses	34.54M
Operating earnings	7.24M
Interest earnings
Interest expense
Foreign exchange gain (loss)
Earnings before income taxes	7.26M
Income tax expense	-1.82M
Net earnings	5.44M
Net earnings per share - basic (in dollars per share)	0.31
Net earnings per share - diluted (in dollars per shares	0.31

Entities mentioned with VASC

View All Entities